ArticleConsortium psychiatricum2026
Mental Health and Quality of Life in Chronic and Recurrent vs First-Episode Dermatophytosis: A Cross-Sectional Study.
Article in Consortium psychiatricum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChronic and recurrent dermatophytosis (CRD) might affect mental health morbidity as well as the quality of life of patients, although it has not been conclusively proven.
aimTo study the quality of life and mental health burden in patients with CRD as compared to those presenting with first-episode superficial dermatophytic infection (SDI).
methodsThe study included patients aged over 18 years with CRD or with first-episode SDI. Quality of life was assessed using the Dermatology Life Quality Index (DLQI), mental health morbidity - using the 12-item General Health Questionnaire (GHQ12) and the Hospital Anxiety and Depression Scale (HADS) defined as the HADS-A (anxiety) and the HADS-D (depression).
resultsA total of 166 patients were examined: 104 with CRD and 62 with first-episode SDI. CRD patients had significantly poorer quality of life, especially in the "extremely large score category" as compared with SDI. The DLQI domains of "symptoms and feelings" and "daily activities" were the worst affected (in all cases
conclusionCRD patients had greater deterioration in mental health (HADS-A) as compared to patients with first-episode superficial dermatophytosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.